HCID 57850477, compound → HCID 53373728, compound

Participants

Reaction Steps

The title compound was prepared by a similar procedure described for step 7 of example 1 using 2-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]-1H-imidazo[4,5-c]pyridin-4-amine (350 mg, 0.95 mmol) and (2S)-1-[4-(2-{[(4-methylphenyl)sulfonyl]oxy}ethyl)piperidin-1-yl]-1-oxopropan-2-yl acetate (662 mg, 1.66 mmol). LC-MS [M+H]+ 590.1. This product is used for the next step without further purification.

Provenance & Evidence